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1. Supporting figures 
 
 
Figure S1: Monitoring the reaction of 1 by HPLC and NMR spectroscopy. (A) HPLC chromatogram of a 
sample of 1 after incubation for 0, 24, 72, and 96 h at 50 °C in methanol. (B) Time-resolved 1H-NMR 
spectrum of 1 in the presence of EP. Over the course of 12 h, spectra were recorded at 1 h intervals. For 
clarity, the figure only displays spectra every 3 hours, namely after 0 (blue), 3 (red), 6 (green), and 9 hours 




Figure S2: EP in complex with reaction products of 1. The mFo-DFc electron density maps for bound 
ligands are depicted as gray meshes at the 3σ level prior to the inclusion of each respective ligand into the 
model. (A) Interaction between EP and molecule 3. The depicted structure EP-3 is the result from a 
diffraction experiment with a crystal soaked with the HPLC isolate m/z = 192.3. Electron density has been 
observed for four copies of compound 3 stacking on top of Phe291 in a regular arrangement. The density 
was sufficient to model the two molecules closest to Phe291 (the second molecule has only been partially 
modeled). The TFA molecule shown in two alternative conformations in orange stems from the HPLC 
purification and binds in a small pocket on the surface of EP. (B) Electron density for molecule 4 in the 
EP binding pocket after soaking of 5, the precursor of 4. While the isolated molecule 4 itself did not bind 
with sufficient occupancy to the enzyme to make it visible in the electron density, the presence of 4 was 
indicated by soaking experiments with the better water-soluble compound 5 that is easily converted into 4 
(Scheme 1 in the main manuscript). For better orientation, the picture contains molecule 2 as a stick model 
in gray, derived from a superimposition of the EP-1-2 onto the EP-4 structure (gray surface 
representation). The bicyclic component of 2 that differentiates it from molecule 4 is depicted in 
transparent colors. Presumably due to its poor aqueous solubility, 4 does not sufficiently occupy the EP 
binding site to allow modelling it in the EP-4 structure. However, for several reasons, we are very 
confident that 4 binds to EP in a similar manner as the corresponding part of 2. In particular, the mFo-DFc 
(gray mesh) electron density map indicates the presence of the substituted pyrrole ring of 4, which is 
further supported by the observation of the alternative conformations of several residues arising from the 
induced-fit binding discussed in Fig. 4B. Presumably, the simultaneous presence of apo and 4-bound EP 
molecules in the crystal also results in electron density next to the aldehyde group of 4 originating from a 
water molecule of the apo protein, which is represented by the red sphere derived from a superimposition 
of the apo structure (PDB-code 4Y5L) onto the EP-4 structure. For clarity, the mFo-DFc map is only 
shown around the pyrrole ring. Moreover, an isomorphous difference map (depicted in green) between the 
EP-4 and a ligand-free EP structure of an isomorphous crystal (PDB-code 5P71) provides some evidence 
for the presence of the tricyclic core of 4 (gray sticks). In contrast, no density could be identified for the 





Figure S3: 1H-13C-HSQC NMR spectrum collected from an EP sample incubated with 1 after an 
incubation time of three weeks at 7 °C. Cross-peaks corresponding to 1 and 4 are annotated in the 
spectrum. Additionally observed signals originate from an unknown molecule, presumably generated from 
hydrolysis of the 3-chloropyridazine moiety in 1. An aldehyde function is clearly present in 4 as indicated 





Figure S4: Comparison of geometric parameters for the proposed methylene bridge of molecule 2 derived 
from the crystallographic experiment (EP-1-2 structure) with results from CSD searches for comparable 
compounds. (A) Definition of the CSD query and investigated geometric parameters. In order to 
investigate whether molecule 4 and 1 are fused to compound 2 via a methylene bridge, the geometric 
parameters highlighted in blue, green, orange, magenta and red derived from the crystallographic 
experiment have been compared with the distributions of the same parameters resulting from a CSD query 
on comparable molecules as defined in the gray box. In the following panels, the mean values and 
standard deviations of the individual histogram peaks are given on top of each plot and compared to the 
crystallographically identified value for 2 including estimated standard deviation (purple, according to the 
SHELXL refinement performed as described in the experimental section). These analyses reveal that 2 
likely harbors an intact methylene bridge. (B) Distribution of the distances between atoms 2 and 3 as 
defined in panel A. (C) Histogram for the distance between atoms 3 and 4. (D) Distribution of the 
methylene bridge angles between atoms 2,3 and 4. (E) Histogram for the torsion angle between atoms 4, 3, 
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2 and 1. If less than 180° rotation of the bond between atoms 4 and 3 in a clockwise fashion (indicated by 
the magenta arrow in panel A) is required in order to create the eclipsed conformation with the bond 
between atoms 2 and 1, the torsion angle is considered positive (else negative) according to IUPAC. (F) 
Histogram for the torsion angle between atoms 2, 3, 4 and 5. If less than 180° rotation of the bond between 
atoms 2 and 3 in a clockwise fashion (indicated by the red arrow in panel A) is required in order to create 
the eclipsed conformation with the bond between atoms 4 and 5, the torsion angle is considered positive 





Figure S5: Comparison of geometric parameters for the proposed aldehyde group of molecule 2 derived 
from the crystallographic experiment (EP-1-2 structure) with results from CSD queries for comparable 
compounds. (A) Definition of the CSD queries and investigated geometric parameters. To decide whether 
2 contains an aldehyde (blue boxes in panel A and transparent blue bars in panels B-D) or alcohol (red) 
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functionality, CSD queries were performed with pyrrole-3-carboxaldehydes and pyrrol-3-ylmethanols 
(left). Since the number of structures containing these motifs in the CSD was rather limited (N = 30 and 4, 
respectively), similar queries have been performed on much more abundant benzaldehydes and 
benzylalcohols (N = 1204 and 475, respectively). The three investigated parameters are defined in green, 
orange and magenta. For instance, the distance between the aldehyde/alcohol carbon and oxygen is 
highlighted in green. (B) Distribution of aldehyde (blue) vs. alcohol (red) bond lengths (between atoms 3 
and 4). The mean values and standard deviations of the individual histogram peaks are given on top of 
each plot and compared to the crystallographically identified value for 2 including estimated standard 
deviation (purple, according to the SHELXL refinement performed as described in the experimental 
section). This comparison clearly indicates that compound 2 contains an aldehyde as supported by similar 
analyses of the associated angle and dihedral (panels C and D). (C) Histogram for the angle between 
atoms 2, 3 and 4 (for the definition of these numbers see panel A). (D) Distribution of torsion angle values 
between atoms 1, 2, 3 and 4. If less than 180° rotation of the bond between atoms 1 and 2 in a clockwise 
fashion (indicated by the magenta arrow in panel A) is required in order to create the eclipsed 
conformation with the bond between atoms 3 and 4, the torsion angle is considered positive (else negative) 





Figure S6: Non-planar pyridazinium and pyridinium cations. (A) Comparison of the non-planarity of the 
pyridazinium heterocycle of molecule 2 as derived from the crystallographic experiment (EP-1-2 
structure) with usual geometric features of pyridazinium ions. A CSD query was set up as defined in the 
gray box. The below histogram reports the distribution of distances between the carbon atom highlighted 
in red from the plane that is made up by the residual atoms of the heterocycle (out-of-plane deviation). 
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The mean values and standard deviation of the single histogram peak is given on top of the plot and 
compared to the crystallographically identified value including estimated standard deviation (purple, 
according to the SHELXL refinement performed as described in the experimental section). (B) 
Comparison of the non-planarity of the pyridazinium heterocycle of molecule 2 with usual geometric 
features of pyridinium ions. Since only seven pyridazinium moieties are currently present in the CSD 
fulfilling our search criteria (for details see also the experimental section), we additionally searched for 
much more frequent pyridinium ions (N = 3107) and plotted the results in the same way as described for 
panel A. Both analyses underline that these heterocyclic cations are usually planar. However, some 
exceptions with significantly shifted carbon positions out of the ring plane do exist. We visually analyzed 
all small molecule crystal structures with d > 0.08 Å including their packing and found that this deviation 
can frequently be attributed to unusually twisted and strained molecular structures as found e.g. in 
helicenes. Two outliers, however, are very interesting with respect to the observed phenomenon (panels C 
and D). Both are host-guest complexes that bear similarities to the EP-1-2 protein-ligand complex (panel 
E). All complexes have two partially negatively charged oxygen atoms in close vicinity to the positively 
charged pyridinium/pyridazinium nitrogen and attached slightly pyramidalized carbon atom. The latter 
atom is highlighted in red along with the distance from the plane while important intermolecular distances 
are shown in orange. (C) A host-guest complex containing a significantly non-planar pyridinium ion 
(CSD-code XUBDAA).[1] (D) A rotaxane containing a slightly distorted pyridinium ion (CSD-code 
XUXGAZ).[2] (E) The high-resolution EP-1-2 crystal structure containing a non-planar pyridazinium 
moiety. The environment of the pyridazinium cation is highlighted. All histograms have been generated 




2. Supporting tables 
 
Table S1: X-ray diffraction data collection and refinement statistics. 
 
Structure EP-2 EP-1-2 EP-3 EP-4 
PDB code 5LWR 5LWS 5LWT 5LWU 
Data collection and processing a         
Wavelength (Å) 0.91841 0.91841 0.91841 0.91841 
Beamline BESSY BL14.2 BESSY BL14.1 BESSY BL14.1 BESSY BL14.1 
Detector MARMOSAIC 225 PILATUS 6M PILATUS 6M PILATUS 6M 
Space group P21 P21 P21 P21 
Cell dimensions  
a, b, c (Å) 45.2, 72.8, 52.6 45.3, 73.1, 53.0 45.4, 73.1, 52.7 45.3, 73.3, 53.1 
α, β, γ (°) 90.0, 109.2, 90.0 90.0, 109.8, 90.0 90.0, 109.6, 90.0 90.0, 109.9, 90.0 
Resolution range (Å) 42.7-1.25 (1.32-1.25) 41.2-1.03 (1.09-1.03) 42.7-1.07 (1.13-1.07) 42.6-1.11 (1.18-1.11) 
Wilson B factor (Å2) 10.5 9.3 9.0 10.3 
No. of unique reflections 87290 (12864) 151655 (23423) 142071 (22805) 128260 (20551) 
Average redundancy 4.0 (3.0) 3.9 (3.8) 3.7 (3.6) 3.7 (3.6) 
Rmerge (%) 3.8 (31.8) 5.5 (51.5) 5.1 (48.5) 4.7 (48.6) 
Completeness (%) 98.1 (89.7) 94.6 (90.6) 99.5 (98.9) 99.6 (99.0) 
<I/σ(I)> 20.7 (3.5) 11.8 (2.3) 13.1 (2.3) 13.5 (2.3) 
Refinement  
Resolution range (Å) 28.1 - 1.25 36.5 - 1.03 29.4 - 1.07 39.8 - 1.11 
No. of reflections (work / free) 82903 / 4363 144059 / 7581 134943 / 7103 121835 / 6413 
Rcryst (%) 11.3 11.6 12.8 12.3 
Rfree (%) 13.1 13.2 14.8 14.3 
No. of refined residues 330 330 330 330 
No. of ligand atoms 38 49 26 
No. of other ligand atoms b 44 47 43 42 
No. of water molecules 329 350 312 326 
RMSD, bond lengths (Å) 0.006 0.007 0.007 0.006 
RMSD, bond angles (˚) 0.9 1.0 1.0 1.0 
Ramachandran plot (%) c  
Most favored 93.9 93.5 94.2 94.2 
Additionally allowed 6.1 6.5 5.8 5.8 
Generously allowed 0 0 0 0 
Disallowed 0 0 0 0 
Average B factors (Å2) d  
All protein atoms 12.0 11.5 11.6 12.6 
Main chain 11.0 10.5 10.7 11.7 
Side chain 12.8 12.5 12.5 13.4 
Ligand atoms 11.7 17.1 30.7 
Other ligand atoms b 21.6 23.2 25.3 25.8 
Waters 29.1 26.1 24.8 27.7 
 
a Values in parenthesis refer to the highest resolution shell 
b Other ligands are glycerol, ethylene glycol, DMSO, acetate and TFA 
c Calculated using PROCHECK[3] 




3. Experimental section 
3.1. General experimental information 
1-Chloro-5,6,7-trimethyl-6H-pyrrolo[3,4-d]pyridazine (1) was purchased as a hydrochloride salt 
from Enamine (UKR). 1H and 13C spectra were recorded on a JEOL ECX-400 or Bruker AV II 
300 instrument. All chemical shift values are reported in ppm relative to the non-deuterated 
solvent signal. Trimethylsilyl propanoic acid was used as an external standard for 13C NMR 
spectra in D2O. To describe the multiplicity of the signal, the following abbreviations were used: 
s = singlet, q = quartet, m = multiplet. ESI-MS spectra were recorded on a Q-Trap 2000 system 
by Applied Biosystems. For high resolution ESI-MS, MS/MS and LC/MS a LTQ-FT Ultra 
(Thermo Fischer Scientific) or Orbitrap Velos Pro (Thermo Fisher Scientific) mass spectrometer 
were used. For HPLC chromatography a Shimadzu LC-20 system equipped with a diode array 
detector was used. Analytic separations were carried out with a MN Nucleodur 100-5 C18ec 4.6 
× 250 mm column using a water-acetonitrile gradient with the addition of 0.1% TFA. For semi-
preparative separations a Waters XSelect CSH C18 10 × 250 mm column using a water-
acetonitrile gradient was used. Preparative separations were carried out on a Varian PrepStar 218 
instrument equipped with a MNagel Nucleodur 100-5 C18ec 32 x 250 mm column, employing a 
water-acetonitrile gradient with the addition of 0.1% TFA. 
3.2. Ageing of compound 1 
To initiate the reaction cascade, a sample of 1 was placed in a clear glass flask or GC-vial, 
dissolved in methanol (Fisher, HPLC grade) and stirred at rt or 50 °C. Preliminary experiments 
were carried out in EP protein buffer (100 mM NaOAc pH 4.6), in the presence and absence of 
EP, respectively, as well as in water at various conditions. Since these experiments did not give 
any additional insight and are comparable to the results in methanol, the details are not reported 
here. For analytical HPLC and MS experiments, 1–5 mg of 1 were dissolved and the resulting 
solution was used as is. The experiment was also carried out with exclusion of sunlight (brown 
glass vial, rt, 24 h) and under protective gas (Argon, rt, 24 h).  
For a semi-preparative separation 20 mg of 1 (HCl salt, 0.09 mmol) were used, the solvent 
methanol was removed after the reaction (24 hours, 50 °C) under reduced pressure and the 
resulting residue was taken up in 1 mL MeOH/H2O 1:9. The crude product was purified on a 
semi-preparative HPLC system equipped with a Waters XSelect CSH C18 (10 x 250 mm) 
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column using a water/acetonitrile gradient. After lyophilization, compound 4 (4 mg, 0.01 mmol, 
13%) was isolated as a light brown solid as the main product of the reaction. 12 mg (0.05 mmol, 
57 %) of the starting material could be recovered. 
The preparative separation was carried out with 100 mg of 1 (HCl salt, 0.43 mmol). The solvent 
methanol was removed after the reaction (24 hours, 50 °C) under reduced pressure and the 
resulting residue was taken up in 2 mL MeOH/H2O 1:9. The crude product was purified on a 
preparative HPLC system using a water/acetonitrile gradient with the addition of 0.1% TFA. 
Fractions that contained a reaction product were collected and lyophilized. Compound 3 (TFA 
salt, < 1 mg, < 3.29 µmol, < 0.76%) was isolated as a light brown solid. Compound 5 (TFA salt, 
31 mg, 0.07 mmol, 15%) was isolated as a red oil as the main product of the reaction. Compound 
6 (TFA salt, < 1 mg, < 1.55 mmol, < 0.4%) was isolated as a red oil. 38 mg (0.12 mmol, 29 %) of 
the starting material could be recovered. 
3.3. Photochemical activation of 1 
A sample of 1 (HCl salt, 108 mg, 0.47 mmol) was dissolved in 200 mL of methanol and placed in 
an immersion-type photochemical reaction apparatus equipped with a 150 W medium pressure 
Hg lamp (Hanau TQ 150). The solution was irradiated for 150 min and the solvent was 
subsequently removed under reduced pressure. The crude product was taken up in 2 mL 
MeOH/H2O 1:9 and subjected to a preparative HPLC separation. After lyophilization, the TFA 
salt of compound 9 (26 mg, 0.07 mmol, 15%) was isolated as a dark oil as the main product of 
the reaction. 
3.4. Conversion of compound 5 to compound 4 
A sample of 5 was placed in a screw cap vial and treated with 10% ammonia solution. After 24 h 
the sample was analyzed by HR-ESI-MS. 
3.5. Tandem MS analysis of compounds 2, 5, 4 and 6 
MS/MS experiments of compounds 2, 5, 4 and 6 were conducted on an Orbitrap Velos Pro 
(Thermo Fischer Scientific) mass spectrometer using an unpurified reaction mixture (24 hours, 50 
°C). Because of a superimposed signal, compound 2 could not be isolated in the ion trap. Instead 
it was analyzed by LC/MS/MS on a LTQ-FT Ultra (Thermo Fischer Scientific) instrument. Due 
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to the low concentration of 2, an ITMS2 configuration had to be used, which resulted in a 
reduced resolution of the spectra. 
 
 
Scheme S1: Tandem MS fragmentation patterns observed for 2, 5, 4 and 6. Experimentally observed 









Table S2: Overview of compounds investigated by quantum chemical calculations. Compounds 
I-X and P-X refer to bicyclic structures (left) while compounds B-X and Pyr-X refer to 
monocyclic structures (right). 
Compound Scaffold Y1 Y2 R1 R2 
I-1 isoindole C C H H 
I-2 isoindole C C H CH3 
I-3 isoindole C C Cl CH3 
I-4 isoindole C-CH3 C Cl CH3 
P-1 isoindole N N H H 
P-2 isoindole N N H CH3 
P-3 (1) isoindole N N Cl CH3 
P-4 isoindole N+-CH3 N Cl CH3 
P-5 indole N N H CH3 
P-6 indole N N Cl CH3 
B-1 monocyclic C C H - 
B-2 monocyclic C C Cl - 
Pyr-1 monocyclic N N H - 
Pyr-2 monocyclic N N Cl - 
 
Structures were initially build with MOE[5] and optimized at the B3LYP/6-31+G(d) level using 
Gaussian09.[6] No imaginary frequencies were found at the stationary points, indicating that the 














































indole ([2',3']-pyrrolo)isoindole ([3',4']-pyrrolo) monocyclic
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structures for single point SCF calculations using different basis sets (6-31G(d), 6-31+G(d) and 
6-311+G(d)). The data trends discussed in the main text refer to calculations on the 6-311G(d) 
level of theory. The detailed results are described in Tables S3 to S16. 
NICS calculation: Absolute NMR-shielding tensors were calculated using the GIAO method.[7] 
The in-plane ring centers (NICS(0)) and out-of-plane ring centers (NICS(1.0)) were calculated 
based on the positions of carbon and nitrogen atoms only.  
NBO Analysis: Wiberg bond indices (WBI) and natural atomic charges were calculated using 
NBO 3.1[8] as implemented in Gaussian09. 
Electrophilicity index : The electrophilicity index  was calculated according to Parr et al.[9] as 
 = ² The chemical potential  is defined as µ = 0.5 · (ELUMO + EHOMO) and the chemical 
hardness  is defined as  = 0.5 · (ELUMO - EHOMO). 
Example Gaussian input file: 
%chk=I-1_6-311+Gd 
 %nproc=2 
 #B3LYP/6-311+G* SCF=tight Test freq nmr pop=nboread IOp(10/46=1) gfprint 
remark line goes here 
<<Coordinates>> 
$NBO RESONANCE NPA NBO NBOSUM BNDIDX E2PERT NLMO DIPOLE NRT PLOT 
$END 
 
3.7. NOESY and HSQC NMR experiments in the presence of endothiapepsin 
NMR measurements were carried out with 300 μl of protein/ligand solution (148 μM EP, 13 mM 
compound 1) in a 50 mM CD3CO2Na buffer at a pD of 5.1 in a Shigemi tube. The time-resolved 
1H- and the [1H-1H]-NOESY spectra (τm=2 s) were measured on a Bruker 800 MHz 1H frequency 
spectrometer, equipped with a triple-resonance cryoprobe, at 298K. 12 consecutive 1H- and 5 
consecutive [1H-1H]-NOESY spectra were recorded every hour, starting from mixing the protein 
and the ligand. The [1H-1H]-NOESY spectra were recorded with 96152(t2)*272(t1) complex 
points, t1max=14.2 ms, t2max=3.0 s, 4 scans, interscan delay 0.3 s. The HSQC spectra were 
measured three weeks after mixing the protein and the ligand, at a Bruker 600 MHz 1H frequency 
spectrometer, equipped with a triple-resonance cryoprobe, at 298K. The HSQC experiment was 
recorded as two separate experiments, focusing on the aliphatic and on the aromatic and carbonyl 
13C chemical shift range, respectively, each with 120 ppm spectral width in the indirect 
dimension, to ensure complete excitation of all 13C nuclei. The phase-sensitive, echo/anti-echo-
17 
 
edited HSQC spectra were recorded with 1024(t2)*128(t1) complex points, t1max=3.5 ms, 
t2max=53.2 ms, 192 scans, and interscan delay of 2 s. 
 
3.8. Crystallization, soaking and X-ray diffraction data collection 
EP was extracted from Suparen samples, kindly supplied by DSM Food Specialties, as described 
previously.[10] Subsequently, the protein was crystallized in its apo-form upon streak-seeding 
using the vapor diffusion method with a mother liquor composed of 100 mM NH4OAc, 100 mM 
NaOAc pH 4.6, 24-30% (w/v) PEG 4000 at 17 °C [11] The originally purchased compound 1 has 
been soaked into EP crystals once at a concentration of 45 mM and thrice at 90 mM resulting in 
the structures EP-1-2 and EP-2, respectively. Following a similar approach, all soaking 
experiments with the compounds isolated via HPLC (1, 3, 4, 5 and 6) have been performed at two 
different concentrations of 90 and 250 mM. At 45 and 90 mM, soaking was performed for 48 h at 
17 °C in 70 mM NH4OAc, 70 mM NaOAc pH 4.6, 16-20% PEG 4000, 23% glycerol, 9% DMSO 
and 45 or 90 mM of the ligand, respectively. At the higher 90 mM ligand concentration, EP 
crystals have been transferred to this solution via a 1:1 mixture of this solution with the 
crystallization mother liquor. The same procedure was also applied at 250 mM where the soaking 
solution consisted of 65 mM NH4OAc, 65 mM NaOAc pH 4.6, 14-18% PEG 4000, 10% 
glycerol, 25% DMSO and 250 mM ligand. In contrast to the 90 mM soaks, the duration of the 
experiment had been reduced to 24 h under the more harsh conditions at 250 mM. Finally, all 
crystals were directly flash-frozen in liquid nitrogen prior to data collection at the BESSY MX 
beamlines BL14.1 and BL14.2.[12] Subsequently diffraction data have been processed using 
XDS.[13] 
 
3.9. Structure determination 
To be able to evaluate and compare the outcome of all diffraction experiments thoroughly, we 
used our automated refinement pipeline[14] to determine structural models for all collected data 
sets via molecular replacement using Phaser[15] and several Phenix[17]-based refinement steps. 
Following this approach, the data set with the highest quality and clearest ligand electron density 
has been chosen for each ligand-bound structure (EP-2: 45 mM, EP-1-2: 90 mM, EP-4: 90 mM, 
EP-3: 250 mM). Subsequently, the associated models were manually further refined against 
structure factor amplitudes until convergence. Library files for all non-standard ligands were 
generated using the Grade web server application.[18] For ligand 2, the obtained restraints have 
been modified in a way to allow the pyridazinium bridge head nitrogen and attached carbon to 
deviate from the ring plane as observed in the unrestrained SHELXL refinement described below. 
In order to obtain a reliable estimate of the real binding-site occupancy of 2, we first refined the 
occupancy of the system Asp33-H2O-Gly221-Thr222 that appeared in two alternative 
conformations, one of which represents the apo-form and one the ligand-bound conformation 
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(Fig. 4B). After validation of the refined value via visual inspection of the anisotropic 
displacement parameters, the resulting occupancy for the latter conformational state was assigned 
also to ligand 2 (67% for EP-2 structure and 63% for EP-1-2). Finally, all resulting structures and 
structure factor amplitudes have been deposited in the PDB. Data collection and refinement 
statistics are given in Table S1. Figures displaying structural information have been prepared 
using Pymol.[19] 
 
3.10. Estimation of standard deviations for different geometric parameters 
To enable an estimation of standard deviations for geometric parameters, a least-squares BLOC 
refinement was performed against intensities using SHELXL.[20] As a starting point, the final 
Phenix-refined EP-1-2 structure has been chosen and adapted in several modeling and refinement 
steps. For the subsequent determination of distances and angles within ligand 2, all of its atoms 
were refined in an unrestrained manner except for planarity restraints for the three ring systems 
excluding the carbon atom next to the pyridazinium nitrogen which was observed to be 
significantly out-of-plane (Fig. 3B). This observation was made via a similar refinement in which 
the planarity restraint for the bicyclic component of 2 was additionally omitted and the deviation 
of each atom of the pyridazinium ring from a least-squares plane made up by the residual five 
atoms of the ring was calculated along with estimated standard deviations. While the bridge head 
pyridazinium nitrogen was found to be located significantly below the plane (-0.20 ± 0.05 Å, 
corresponding to -4.1 σ) and the attached carbon atom accordingly above the plane (0.23 ± 0.05 
Å, corresponding to 4.3 σ), all other atoms did not deviate as significantly from their respective 
planes (-0.11 to 0.06 Å, -2.1 to 1.1 σ). In order to ensure that these results had not been biased by 
the ligand restraints used in the previous Phenix-based refinement steps, we repeated both 
analyses with starting structures that contained an alcohol CO bond length of 1.41 Å instead of 
the aldehyde bond length of 1.22 Å and an approximately planar pyridazinium ring, respectively. 
Importantly, the results did not deviate significantly from those obtained before. 
 
3.11. Queries in the Cambridge Structural Database (CSD) 
CSD searches have been performed using Conquest[21] vs. 1.18 based on CSD vs. 5.37 as of 
November 2015 (with 2 updates) while the results were analyzed with Mercury[22] vs. 3.8 and 
plotted via the statistical program R.[23] The following adjustments have been used for all 
searches: 3D coordinates determined, only organics, R ≤ 0.075, not disordered, no errors and not 
polymeric. The investigated chemical structures and geometric parameters are defined in Figs. 




4. Experimental data 
Compound 1. 1H NMR (400 MHz, D2O) δ = 2.78 (s, 3H), 2.85 (s, 3H), 3.97 (s, 3H), 9.53 (s, 
1H). 13C NMR (101 MHz, D2O) δ = 10.3, 10.7, 32.8, 110.4, 113.5, 129.6, 136.5, 142.4, 150.9. 
HRMS (ESI+) calculated for C9H11ClN3: 196.0636 [M+H]+; found: 196.0636. 
Compound 2. HRMS (ESI+) calculated for C27H29ClN9O: 530.2178 [M]+; found: 530.2176. 
Compound 3 (TFA salt). 1H NMR (400 MHz, D2O) δ = 2.63 (s, 3H), 2.65 (s, 3H), 3.81 (s, 3H), 
4.11 (s, 3H), 9.15 (s, 1H). HRMS (ESI+) calculated for C10H14N3O: 192.1131 [M+H]+; found: 
192.1128. 
Compound 4.a 1H NMR (400 MHz, MeOH-d4) δ = 2.26 (s, 3H), 2.62 (s, 3H), 2.63 (s, 3H), 2.80 
(s, 3H), 3.63 (s, 3H), 3.81 (s, 3H), 8.52 (s, 1H), 9.70 (s, 1H). 13C NMR (101 MHz, MeOH-d4) δ 
= 10.4, 10.8, 11.0, 11.8, 30.9, 31.7, 111.8, 125.3, 133.6, 143.8, 170.3. HRMS (ESI+) calculated 
for C18H21N6O: 337.1771 [M+H]+; found: 337.1767. 
Compound 5 (TFA salt). 1H NMR (400 MHz, D2O) δ = 2.45 (s, 3H), 2.80 (s, 3H), 2.83 (s, 3H), 
2.87 (s, 2H), 3.95 (s, 3H), 3.97 (s, 2H), 9.70 (s, 1H). 13C NMR (101 MHz, D2O) δ = 10.6, 10.8, 
10.9, 12.3, 33.4, 105.6, 109.4, 115.6, 116.2 (q, 1JCF = 288.7), 116.4, 128.5, 132.1, 138.4, 142.9, 
144.0, 144.9, 150.4, 151.4, 162.9 (q, 2JCF = 35.2). HRMS (ESI+) calculated for C18H20ClN6: 
355.1438 [M]+; found: 355.1433. 
Compound 6 (TFA salt). 1H NMR (400 MHz, D2O) δ = 2.32 (s, 3H), 2.54 (s, 3H), 2.75 (s, 3H), 
2.79 (s, 3H), 2.87 (s, 3H), 2.93 (s, 3H), 3.89 (s, 3H), 3.95 (s, 3H), 4.04 (s, 3H), 9.74 (s, 1H), 10.15 
(s, 1H), 10.44 (s, 1H). HRMS (ESI+) calculated for C27H31ClN9O: 532.2335 [M]+; found: 
532.2334. 
Compound 8. HRMS (ESI+) calculated for C10H13ClN3O: 226.0742 [M+H]+; found: 226.0730. 
Compound 9 (TFA salt). 1H NMR (400 MHz, D2O) δ = 3.44 – 3.49 (m, 6H), 4.14 (s, 3H), 5.07 
(s, 2H), 5.18 (s, 2H), 9.84 (s, 1H). 13C NMR (101 MHz, D2O) δ = 33.8, 57.6, 58.2, 61.5, 63.2, 
114.2, 115.6, 116.2 (q, 1JCF = 291.7), 128.0, 135.1, 143.1, 150.9, 162.8 (q, 2JCF = 43.1). HRMS 
(ESI+) calculated for C11H15ClN3O2: 256.0847 [M+H]+; found: 256.0833. 
a Due to its poor solubility, compound 4 was dissolved in a mixture of MeOH-d4 and acetone-d6. 
The low concentration prohibited the observation of several signals of quaternary carbon atoms in 




5. Data from quantum chemical calculations 
 
Table S3: Natural atomic charges at atom position 4. 
Compound 6-31G(d) 6-31+G(d) 6-311+G(d) 
I-1 -0.21638 -0.21759 -0.18359 
I-2 -0.21592 -0.21616 -0.18410 
I-3 -0.01476 -0.01326 -0.00804 
I-4 -0.00645 -0.00394 0.01021 
P-1 0.03557 0.03206 0.06757 
P-2 0.03546 0.03085 0.08457 
P-3 (1) 0.22077 0.20894 0.22538 
P-4 0.23685 0.22813 0.24438 
P-5 -0.03548 -0.03769 -0.00296 
P-6 0.15427 0.14564 0.16039 
B-1 -0.23527 -0.24218 -0.20333 
B-2 -0.23848 -0.24463 -0.20632 
Pyr-1 -0.01251 -0.02041 0.02052 
Pyr-2 -0.01417 -0.02107 0.01868 
 
Table S4: Natural atomic charges at atom position 1. 
Compound 6-31G(d) 6-31+G(d) 6-311+G(d) 
I-1 -0.21638 -0.21759 -0.18359 
I-2 -0.21594 -0.21959 -0.17120 
I-3 -0.21468 -0.21542 -0.17048 
I-4 -0.21542 -0.21410 -0.18760 
P-1 0.03439 0.03198 0.06752 
P-2 0.03546 0.03378 0.06459 
P-3 (1) 0.03818 0.03664 0.07056 
P-4 0.12658 0.13490 0.16506 
P-5 0.01105 0.00766 0.04347 
P-6 0.01253 0.00908 0.04383 
B-1 -0.23527 -0.24218 -0.20333 
B-2 -0.04358 -0.05584 -0.04102 
Pyr-1 -0.01251 -0.02041 0.02052 




Table S5: WBI for atomic bond at position 2-3. 
Compound 6-31G(d) 6-31+G(d) 6-311+G(d) 
I-1 1.2657 1.2663 1.2669 
I-2 1.2604 1.2603 1.2167 
I-3 1.2556 1.2542 1.2535 
I-4 1.2204 1.2198 1.2167 
P-1 1.2191 1.2227 1.2239 
P-2 1.2107 1.2129 1.2147 
P-3 (1) 1.1936 1.1945 1.1935 
P-4 1.1269 1.1302 1.1264 
P-5 1.335 1.3374 1.3397 
P-6 1.3086 1.3095 1.3097 
B-1 1.4368 1.4371 1.439 
B-2 1.432 1.4324 1.4327 
Pyr-1 1.3976 1.4027 1.4047 
Pyr-2 1.3736 1.3765 1.3763 
 
Table S6: WBI for atomic bond at position 3-4. 
Compound 6-31G(d) 6-31+G(d) 6-311+G(d) 
I-1 1.5988 1.5980 1.6005 
I-2 1.6013 1.6004 1.5679 
I-3 1.5624 1.5598 1.5623 
I-4 1.5758 1.5735 1.5679 
P-1 1.6445 1.6473 1.6468 
P-2 1.6492 1.6504 1.6436 
P-3 (1) 1.6370 1.6387 1.6356 
P-4 1.5705 1.5672 1.5648 
P-5 1.5291 1.531 1.5299 
P-6 1.5408 1.5451 1.5437 
B-1 1.4368 1.4371 1.439 
B-2 1.4037 1.4027 1.4025 
Pyr-1 1.4824 1.4866 1.4856 






Table S7: NICS(0) values at ring A. 
Compound 6-31G(d) [ppm] 6-31+G(d) [ppm] 6-311+G(d) [ppm] 
I-1 -8.3573 -6.7175 -6.5780 
I-2 -7.8801 -6.3974 -6.1650 
I-3 -8.1807 -7.3796 -7.4937 
I-4 -8.6765 -7.3959 -7.0781 
P-1 -5.0951 -4.4809 -4.5637 
P-2 -4.6257 -4.1097 -4.1701 
P-3 (1) -5.6378 -4.9806 -4.9024 
P-4 -6.2992 -5.5065 -5.2127 
P-5 -8.9700 -8.3265 -8.3780 
P-6 -8.9700 -8.3265 -8.3780 
B-1 -9.6482 -8.0216 -7.9345 
B-2 -10.2524 -8.9027 -9.9924 
Pyr-1 -5.7556 -5.0531 -5.2485 
Pyr-2 -6.4445 -5.8008 -5.8481 
 
Table S8: NICS(0) values at ring B. 
Compound 6-31G(d) [ppm] 6-31+G(d) [ppm] 6-311+G(d) [ppm] 
I-1 -17.4253 -15.6495 -15.3332 
I-2 -16.8376 -15.3714 -15.2396 
I-3 -17.2753 -16.0619 -15.8239 
I-4 -16.9905 -15.5229 -15.2236 
P-1 -17.9539 -16.4588 -16.0083 
P-2 -17.3109 -15.8880 -15.6712 
P-3 (1) -17.4879 -16.4384 -16.1498 
P-4 -16.6222 -15.4282 -15.1428 
P-5 -13.5300 -12.7020 -12.3425 









Table S9: NICSZZ(0) values at ring A. 
Compound 6-31G(d) [ppm] 6-31+G(d) [ppm] 6-311+G(d) [ppm] 
I-1 -5.6777 -5.4037 -6.0251 
I-2 -3.1337 -2.8154 -3.4881 
I-3 -29.4937 -29.6613 -30.4412 
I-4 -2.5119 -1.9326 -2.4267 
P-1 -2.4149 -2.4149 -3.5926 
P-2 0.1742 0.1742 -0.9561 
P-3 (1) 0.0075 0.0075 -0.7008 
P-4 4.2965 4.6270 4.4654 
P-5 -11.4265 -11.9404 -12.6243 
P-6 -10.2845 -10.4693 -11.0410 
B-1 -13.7989 -13.1765 -14.0643 
B-2 -13.3587 -12.6903 -13.3565 
Pyr-1 -10.4678 -10.7302 -11.5122 
Pyr-2 -9.8905 -9.8762 -10.4523 
 
Table S10: NICSZZ(0) values at ring B. 
Compound 6-31G(d) [ppm] 6-31+G(d) [ppm] 6-311+G(d) [ppm] 
I-1 -16.6309 -16.1241 -16.6410 
I-2 -13.8302 -13.8624 -14.5943 
I-3 -13.8886 -13.9385 -14.6399 
I-4 -12.6404 -12.2745 -12.9272 
P-1 -16.7125 -16.7125 -16.8537 
P-2 -13.7984 -13.7984 -14.5550 
P-3 (1) -13.5122 -13.5122 -14.1549 
P-4 -12.9942 -12.6259 -13.3833 
P-5 -28.3137 -28.2621 -28.3954 









Table S11: NICS(1.0) values at ring A. 
Compound 6-31G(d) [ppm] 6-31+G(d) [ppm] 6-311+G(d) [ppm] 
I-1 -9.4985 -8.2738 -8.4818 
I-2 -9.0535 -7.9922 -8.1357 
I-3 -9.1508 -8.0746 -8.0797 
I-4 -8.9200 -7.8523 -7.8267 
P-1 -9.2444 -8.3725 -8.5583 
P-2 -8.5047 -7.7288 -7.9358 
P-3 (1) -8.2936 -7.4413 -7.6149 
P-4 -7.2098 -6.4063 -6.4560 
P-5 -11.7000 -10.8731 -11.0804 
P-6 -11.1418 -10.3154 -10.5151 
B-1 -11.1929 -10.1364 -10.1345 
B-2 -11.0419 -9.9924 -10.0023 
Pyr-1 -11.0397 -10.2596 -10.4739 
Pyr-2 -10.6968 -9.9392 -10.0860 
 
Table S12: NICS(1.0) values at ring B. 
Compound 6-31G(d) [ppm] 6-31+G(d) [ppm] 6-311+G(d) [ppm] 
I-1 -13.8887 -12.2812 -12.3669 
I-2 -13.6878 -12.2126 -12.4800 
I-3 -13.7288 -12.3437 -12.3577 
I-4 -13.4765 -12.0651 -12.1919 
P-1 -14.1433 -12.7693 -12.8363 
P-2 -13.8699 -12.5762 -12.9047 
P-3 (1) -13.7434 -12.5977 -12.6247 
P-4 -14.0630 -12.8504 -12.9812 
P-5 -11.3494 -10.4291 -10.5042 









Table S13: HOMO energies 
Compound 6-31G(d) [eV] 6-31+G(d) [eV] 6-311+G(d) [eV] 
I-1 -4.72988 -5.05424 -5.09887 
I-2 -4.37777 -4.65396 -4.69968 
I-3 -4.64471 -4.8942 -4.93941 
I-4 -4.58593 -4.82294 -4.86839 
P-1 -5.78840 -6.11440 -6.15957 
P-2 -5.33942 -5.61997 -5.66514 
P-3 (1) -5.62486 -5.88065 -5.92555 
P-4 -9.84780 -9.98250 -10.02440 
P-5 -5.7751 -6.1315 -6.1645 
P-6 -6.1476 -6.3922 -6.4390 
B-1 -6.6940 -6.9939 -7.0385 
B-2 -6.7016 -6.9457 -6.9822 
Pyr-1 -6.3465 -6.6997 -6.7332 
Pyr-2 -6.8390 -7.1514 -7.1835 
 
Table S14: LUMO energies 
Compound 6-31G(d) [eV] 6-31+G(d) [eV] 6-311+G(d) [eV] 
I-1 -0.38612 -0.78994 -0.78994 
I-2 -0.27946 -0.63456 -0.63456 
I-3 -0.59592 -0.91375 -0.91375 
I-4 -0.51211 -0.81253 -0.81253 
P-1 -1.1428 -1.50479 -1.50479 
P-2 -0.97117 -1.28764 -1.28764 
P-3 (1) -1.25417 -1.53227 -1.53227 
P-4 -5.92909 -6.07902 -6.07902 
P-5 -0.6664 -1.0275 -1.0917 
P-6 -0.9285 -1.2251 -1.2912 
B-1 0.0841 -0.3951 -0.4620 
B-2 -0.3499 -0.7761 -0.8444 
Pyr-1 -1.3910 -1.7979 -1.8618 






Table S15: HOMO-LUMO energy gaps 
Compound 6-31G(d) [eV] 6-31+G(d) [eV] 6-311+G(d) [eV] 
I-1 -4.34375 -4.26429 -4.30892 
I-2 -4.09830 -4.01939 -4.06511 
I-3 -4.04878 -3.98048 -4.02565 
I-4 -4.07381 -4.01041 -4.05585 
P-1 -4.64553 -4.60961 -4.65478 
P-2 -4.36824 -4.33232 -4.37749 
P-3 (1) -4.37069 -4.34838 -4.39328 
P-4 -3.91871 -3.90347 -3.94538 
P-5 -5.1087 -5.1040 -5.0727 
P-6 -5.2191 -5.1672 -5.1479 
B-1 -6.7781 -6.5988 -6.5765 
B-2 -6.3517 -6.1696 -6.1378 
Pyr-1 -4.9555 -4.9019 -4.8714 
Pyr-2 -5.0238 -4.9772 -4.9459 
 
Table S16: Electrophilicity index . 
Compound 6-31G(d) [eV] 6-31+G(d) [eV] 6-311+G(d) [eV] 
I-1 1.5064 2.0023 2.0120 
I-2 1.3231 1.7396 1.7499 
I-3 1.6958 2.1186 2.1276 
I-4 1.5949 1.9798 1.9893 
P-1 2.5853 3.1484 3.1550 
P-2 2.2791 2.7534 2.7608 
P-3 (1) 2.7067 3.1593 3.1650 
P-4 15.8796 16.5220 16.4319 
P-5 2.0305 2.5104 2.5949 
P-6 2.3984 2.8073 2.9020 
B-1 1.6115 2.0685 2.1386 
B-2 1.9571 2.4161 2.4950 
Pyr-1 3.0204 3.6827 3.7912 





6. Data from NMR, MS, and HPLC experiments 
6.1. NMR spectroscopy 











1H (400 MHz, MeOH-d4) and 13C NMR (101 MHz, MeOH-d4) spectra of compound 4 
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1H (400 MHz, D2O) NMR spectrum of compound 9 
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6.2. Mass spectrometry 










160406_LC_019_Kl #1334 RT: 13.45 AV: 1 NL: 1.33E6
F: ITMS + c ESI Full ms [100.00-1000.00]









































512.4133.3 222.2 689.4544.3381.3293.4 433.1415.2 690.3562.3494.4448.2 671.4 721.3592.3 625.1 848.3755.3 781.8 866.4 911.4 972.7933.2
















































RT: 13.42  AV: 1 F: FTMS + p 
ESI Full ms [100.00-1000.00] 
NL:
1.28E4
C 27 H29 ClN9 O: 
C 27 H29 Cl1 N9 O1
p (gss, s /p:40) Chrg 1
R: 50000 Res .Pwr . @FWHM
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160518_LC_028_Kl_1 #905-971 RT: 12.76-13.61 AV: 11 SM: 7B NL: 1.33E2
F: FTMS + p ESI Full ms [500.00-600.00]






























































160518_LC_028_Kl_1 #966-994 RT: 13.64-13.98 AV: 5 NL: 4.67E2
F: ITMS + c ESI Full ms2 530.20@cid35.00 [145.00-2000.00]











































196.0 368.2 385.3 520.4357.2305.1 317.4291.1231.2 267.1190.1 249.2203.2165.1 616.6555.7 571.5522.4 603.0 634.1
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MS/MS Spectra of compound 4
 
160518_SY_026_Kl_2 #311-328 RT: 4.73-4.99 AV: 18 SM: 7B NL: 3.67E5
F: FTMS + p NSI w Full ms2 337.20@cid35.00 [90.00-600.00]




































































160518_SY_026_Kl_2 #311-328 RT: 4.73-4.99 AV: 18 SM: 7B NL: 1.85E5
F: FTMS + p NSI w Full ms2 337.20@cid35.00 [90.00-600.00]








































































160518_SY_026_Kl_2 #311-328 RT: 4.73-4.99 AV: 18 SM: 7B NL: 2.08E4
F: FTMS + p NSI w Full ms2 337.20@cid35.00 [90.00-600.00]








































































160518_SY_026_Kl_2 #259-275 RT: 3.87-4.14 AV: 17 SM: 7B NL: 7.45E4
F: FTMS + p NSI Full ms3 337.20@cid35.00 308.20@cid35.00 [80.00-600.00]







































































MS/MS Spectrum of compound 5 
 
  
160518_SY_026_Kl_2 #74-107 RT: 1.11-1.59 AV: 34 SM: 7B NL: 4.78E6
F: FTMS + p NSI Full ms2 356.10@cid35.00 [95.00-600.00]








































































MS/MS Spectra of compound 6 
 
 
160518_SY_026_Kl_1 #5-65 RT: 0.04-0.48 AV: 61 SM: 7B NL: 7.40E5
F: FTMS + p NSI Full ms [400.00-1000.00]




































































160518_SY_026_Kl_1 #858-967 RT: 7.23-8.47 AV: 107 SM: 7B NL: 5.11E3
F: FTMS + p NSI Full ms2 533.30@hcd35.00 [50.00-600.00]










































































160518_SY_026_Kl_1 #858-967 RT: 7.23-8.47 AV: 107 SM: 7B NL: 5.11E3
F: FTMS + p NSI Full ms2 533.30@hcd35.00 [50.00-600.00]




































































160518_SY_026_Kl_1 #858-967 RT: 7.23-8.47 AV: 107 SM: 7B NL: 1.22E3
F: FTMS + p NSI Full ms2 533.30@hcd35.00 [50.00-600.00]























































































160518_SY_026_Kl_1 #809-849 RT: 6.64-7.08 AV: 39 SM: 7B NL: 1.33E1
F: FTMS + p NSI Full ms2 533.30@hcd35.00 [191.00-201.00]
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